Search results for " COVID-19"
Article
Top Process Development Trends for 2022 and a Look into 2023
In parallel, brought on by the obvious commercial success of the warp speed program for COVID-19 vaccines, came a need for reduced timelines, which accelerated the ongoing Industry 4:0 analytics, digi…
Article
Advancing Global Collaboration for Drug Testing, Regulation, and Manufacturing
While some initiatives predated the COVID-19 pandemic, the ongoing health emergency has elevated the importance of collaboration to speed biomedical research efforts and to ensure broad access to qual…
Article
Increasing mRNA capabilities and capacity for growing market needs
The rapid development of innovative vaccines allowed for the pharmaceutical industry to deliver its first tools in the fight against the COVID-19 pandemic.
READ FULL ARTICLE >>
Article
mRNA Vaccines: Current Trends and Perspectives
There are still challenges to overcome to fully realize the potential of this technology, but the COVID-19 pandemic publicly demonstrated the promise of mRNA therapies. The future looks bright for thi…
Article
Increasing mRNA Capabilities and Capacity for Growing Market Needs
Click here to read more >>
The success of the mRNA vaccine market is fueling high demand for mRNA, resulting in a critical need to address the manufacturing bottlenecks.
Article
Regulatory Requirements for Safe and Efficient Biologic Drug Development
STEVE
Click here to view more Industry Leader Q&As >>
Steven Lynn, Executive Vice-President, Pharmaceuticals, Regulatory Compliance Associates, shares insight into regulatory require…
Article
Single-Use Technologies Are Here to Stay: How Can We Improve Their Supply?
Click here to read more >>
The use of single-use technologies has been growing steadily, but supply constraint is a key challenge for the biopharma industry. This article discusses the potenti…
Article
Cytiva Invests $500 Million Over 5 Years to Expand Global Capacity
The industry is growing rapidly, now even more due to COVID-19. Accelerating this investment will reinforce these commitments,” said Emmanuel Ligner, president and CEO, Cytiva, in the press release. "…
Article
Mechanistic Modeling: Current Advantages and Future Opportunities in Biopharmaceutical Process Development
But especially in the current COVID-19 situation, the benefits of mechanistic modeling become increasingly obvious. Wet lab work, for example, is difficult to carry out in times of social distancing a…
Article
Manufacturing of Vaccines and Viral Vectors
Click here to read the article >>
With the pandemic outbreak of COVID-19, there is intense focus on developing a vaccine. However, the challenge not only lies in developing a vaccine but also i…